Success breeds imitation. The persistence of that cliché is good evidence of its accuracy. Its implications, however, may be a warning call with respect to shareholder activism in Canada. The woes of Valeant Pharmaceuticals International Inc. (“Valeant”) and its share price have been well documented in the media. Following a report by Citron Research, who … Continue reading
Norton Rose Fulbright Canada has recently been involved in the introduction and adoption of forum selection by-laws in Canada. This article will provide a brief description of forum selection by-laws and their benefits and uses. For a more in-depth analysis, we invite readers to watch the replay of the talk or reach out to the … Continue reading
When most people think shareholder activism, they think big names and big hedge funds – Carl Icahn, Bill Ackman, Jana Partners – who have the wherewithal to obtain a sizeable stake in the target company. However, as explored by Ronald Barusch in the Wall Street Journal, a new form of activism, spearheaded by a former … Continue reading